Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study
恩沙替尼(X-396)治疗ALK阳性非小细胞肺癌:一项首次人体I/II期多中心研究的结果
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-17-2398
Horn, Leora; Infante, Jeffrey R; Reckamp, Karen L; Blumenschein, George R; Leal, Ticiana A; Waqar, Saiama N; Gitlitz, Barbara J; Sanborn, Rachel E; Whisenant, Jennifer G; Du, Liping; Neal, Joel W; Gockerman, Jon P; Dukart, Gary; Harrow, Kimberly; Liang, Chris; Gibbons, James J; Holzhausen, Allison; Lovly, Christine M; Wakelee, Heather A